TG Therapeutics Inc.

10/14/2021 | Press release | Distributed by Public on 10/14/2021 08:54

TG Therapeutics Announces Data for Ublituximab in Multiple Sclerosis Presented at the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis